Prelude Capital Management’s Xilio Therapeutics XLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-29,500
Closed -$31.9K 1438
2024
Q1
$31.9K Buy
+29,500
New +$31.9K ﹤0.01% 1154